Supplementation of conventional therapy with the novel grain Salba (Salvia hispanica L.) improves major and emerging cardiovascular risk factors in type 2 diabetes: results of a randomized controlled trial (Q34005622)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Supplementation of conventional therapy with the novel grain Salba (Salvia hispanica L.) improves major and emerging cardiovascular risk factors in type 2 diabetes: results of a randomized controlled trial |
scientific article |
Statements
1 reference
Supplementation of conventional therapy with the novel grain Salba (Salvia hispanica L.) improves major and emerging cardiovascular risk factors in type 2 diabetes: results of a randomized controlled trial (English)
1 reference
Vladimir Vuksan
1 reference
Dana Whitham
1 reference
John L Sievenpiper
1 reference
Alexandra L Jenkins
1 reference
Alexander L Rogovik
1 reference
Richard P Bazinet
1 reference
Edward Vidgen
1 reference
Amir Hanna
1 reference
Identifiers
1 reference